Anti-TRIAP1 antibodies are used in the immunodetection of the protein TP53 regulated inhibitor of apoptosis 1. In humans, the canonical protein has a reported length of 76 amino acid residues and a mass of 8.8 kDa. Its subcellular localization is in the mitochondria. It is notably widely expressed in many tissue types. A member of the TRIAP1/MDM35 protein family, TRIAP1 is reported to be involved in modulation of the mitochondrial apoptotic pathway by ensuring the accumulation of cardiolipin (CL) in mitochondrial membranes. Synonyms for this target antigen include MDM35, P53CSV, WF-1, mitochondrial distribution and morphology 35 homolog, p53-inducible cell-survival factor, and HSPC132. TRIAP1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some TRIAP1 antibodies may have been used in research and have associated citations. Immunofluorescence is a widely used application for these antibodies. Western Blot, Immunocytochemistry, and Immunohistochemistry are also common applications.